In an editorial, UK’s government was criticized for being slow to respond to the pandemic by not following instructive experiences from other countries. China’s aggressive approach to locking down cities has slowed the spread of the virus in its country
Read More
In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, convalescent plasma containing neutralizing antibody showed promising results in treating severe cases. These observations require evaluation in clinical trials. We would really like to have
Read More
This study comparing patients who died from COVID to those who recovered details some laboratory values that are more/less common as well as the most common complications. This study compared the clinical characteristics of 113 patients who died from COVID
Read More
This study investigated the case fatality rate (CFR) among confirmed COVID-19 cases (N=22,512) in Italy, using Italian National Institute of Health surveillance data up to March 17, 2020. The overall fatality rate of persons with confirmed COVID-19 in the Italian
Read More
This study concluded that children of all ages are susceptible to COVID-19, with no significant gender differences. Young children, particularly infants, are more vulnerable to infection. Objective: To identify the epidemiological characteristics and transmission patterns of children infected with COVID-19
Read More
This modeling study argues that undocumented cases are very common and lead to most of the spread of SARS-CoV2. One of the biggest concerns of public health officials is that people can be infected with SARS-CoV2, not know it, and
Read More
This study provides key data on how long it takes to develop antibodies after symptoms of COVID (5 days for IgM and IgA, and 14 days for IgG) and argues that combining IgM ELISA assay with PCR makes a false
Read More